Reperfused Myocardial Infarction is a research paper published in JACC Advances (2025). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL133407
National Institutes of Health
Grant: HL136578
National Institutes of Health
Grant: HL147133
NHLBI NIH HHS
Grant: R01 HL133407
NHLBI NIH HHS
Grant: R01 HL147133
National Institutes of Health
Grant: 1R01HL133407-01A1
Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure
National Institutes of Health
Grant: 5R01HL136578-03
An Accurate Non-Contrast-Enhanced Cardiac MRI Method for Imaging Chronic Myocardial Infarctions: Technical Developments to Rapid Clinical Validation
National Institutes of Health
Grant: 5R01HL147133-02
Mechanistic Insights to A Translatable Therapy for Acute Reperfused Hemorrhagic Myocardial Infarctions
GlaxoSmithKline
Pfizer
FWCI
12.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals